SAN DIEGO, Feb. 26, 2026 /PRNewswire/ — Avidity Biosciences, Inc. (“Avidity”) (Nasdaq: RNA), a biopharmaceutical company committed to delivering a…
Read More
The chondrosarcoma market is anticipated to increase during the forecast period (2026–2036), owing to improved diagnosis, treatment advancements, increased awareness,…
Read More
ARLINGTON, Va., Feb. 26, 2026 /PRNewswire/ — The American Academy of Physician Associates (AAPA), representing approximately the nation’s 190,000 physician…
Read More